Weill Cornell Medicine has received a $1.27 million grant from the United States Department of Defense (DoD) to develop treatment for a rare but devastating eye condition largely affecting military personnel who suffer traumatic eye injuries in combat.
Low levels of a clot-busting protein may explain why some people are at higher risk of blood-clotting disorders, according to a new study by Weill Cornell Medicine and NewYork-Presbyterian investigators.
When Cornell President Martha E. Pollack talks about the experiences that shaped her career, she starts by talking about mentorship, and a pivotal conversation she had with Professor Hoyt Alverson at Dartmouth College.
Dr. Kyu Rhee, an associate professor of medicine in the Division of Infectious Diseases at Weill Cornell Medicine, has been awarded a Physician-Scientist Institutional Award by the Burroughs Wellcome Fund.
A protein found in the cells lining blood vessels plays a central role in preventing fluid and inflammatory cells from leaking into lung tissue in a low-oxygen environment, Weill Cornell Medicine researchers discovered.